Biphasic cancer cells have recently been found to be more common than originally thought in mesothelioma patients, and have been identified as the second most common type of cells in this asbestos related cancer. Biphasic mesothelioma cells are described as a combination of sarcomatoid mesothelioma cells and epitheloid mesothelioma cells. Biphasic cells are usually identified through the performance of a biopsy, which is a process where tissue sample is taken for examination.
Biphasic mesothelioma is also known as mixed mesothelioma, and the combination of sarcomatoid cells and epitheloid cells can vary in structure, with some forms of biphasic mesothelioma entailing a combination of the two types of cells intermingled together, and other forms entailing the two types of cells being separated in different parts of the tumor.
Although treatment options available for those with biphasic mesothelioma are basically the same as those offered to patients with sarcomatoid mesothelioma or epitheloid mesothelioma, the average lifespan for patients with biphasic mesothelioma is shorter than the others, with the average survival time being around six months.
Mesothelioma is a type of malignant cancer that stems from long-term or high-level exposure to asbestos fibers and dust that have become airborne. Although there is no cure for mesothelioma, continuous efforts are being made to try and find a more effective treatment that will help to extend the patient’s lifespan, as this can be shortened to a matter of months following diagnosis of the cancer.
Thank you for choosing Lawcore.com!